Clinical Trial Update: Minimizing Toxicity in HLA-identical Sibling Donor Transplantation for Children With Sickle Cell Disease [Phase 2]

View source ↗

Summary

A Phase 2 study aims to minimize transplant toxicity in HLA-identical sibling donor transplantation for children with sickle cell disease; the trial is currentl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease

Snippet

Sponsor: Robert Nickel | Conditions: Sickle Cell Disease | Phase 2 | Status: RECRUITING